WPI 845 Pill - white round, 6mm

Pill with imprint WPI 845 is White, Round and has been identified as Glipizide Extended Release 10 mg. It is supplied by Watson Laboratories, Inc.

Glipizide is used in the treatment of Diabetes, Type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 845

Glipizide extended release 10 mg WPI 845

Glipizide extended release 10 mg WPI 845 Front

Glipizide extended release 10 mg WPI 845 Back

Glipizide Extended Release

Imprint: WPI 845
Strength: 10 mg
Color: White
Size: 6.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Sulfonylureas
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Watson Laboratories, Inc.
Inactive Ingredients: acetyltributyl citrate, ammonia, butyl alcohol, ferrosoferric oxide, hydroxyethyl cellulose (2000 mpa.s at 1%), isopropyl alcohol, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol 400, propylene glycol, shellac
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00591-0845	Watson Pharmaceuticals, Inc.
68084-0112	Amerisource Health Services
10370-0191 (Discontinued)	Anchen Pharmaceuticals, Inc.
54569-5548	A-S Medication Solutions, LLC (repackager)
54868-4988 (Discontinued)	Physicians Total Care Inc. (repackager)
55289-0301	PDRX Pharmaceuticals Inc. (repackager)